The global demand for Microneedle Drug Delivery Systems Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Micro Needle Drug Delivery System is a systemic drug delivery device used to administer drugs/vaccines by penetrating the outermost layer of the skin. This system compromises of a microneedle and a drug patch. These microneedles can be dissolvable and degradable. The use of microneedle benefits the health care sectors since it improves the comfort of patients especially those with needle phobia. It also reduces the rate of microbial invasion at the delivery point. Various types of micro needles can be produced depending on the nature of use and the type of material. The only issue associated with these micro needles is that they are very small in size and can remain under the skin due to breakage if not administered with caution. They are very convenient to use that they can enable self administration of medicines as well.
The market of microneedle drug delivery systems is bound to grow at an alarming rate because of its ease of use, growth in research and development initiatives, need for safer alternatives to vaccinate people in large numbers. The need for minimally trained health care professionals to administer, ease of storage, distribution, and disposal can boost the market growth. This system can exhibit few inferior characteristics like drug degradation, irritation on the site of application, poor absorption which can act as restraining factors for market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of microneedle drug delivery systems.
The entire microneedle drug delivery systems market has been sub-categorized into product type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product Type
- Solid Microneedle Technology
- Hollow Microneedle Technology
- Dissolving Microneedle Technology
- Drug Delivery
- Vaccine Delivery
This section covers regional segmentation which accentuates on current and future demand for microneedle drug delivery systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Microneedle Drug Delivery Systems Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the microneedle drug delivery systems market include 3M Company, Becton-Dickinson BD Technologies, Nanopass Technologies Ltd., Corium Inc., Microdermics, TheraJect Inc., Johnson & Johnson, Lohmann Therapie-Systeme AG, Novartis, Bayer. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.